Opioid Diversion, Postal Carrier Dangers Among Industry Concerns With Mail-Back Envelope Requirement

Pills in envelope
Industry trade groups raised several concerns about an FDA proposal to require pre-paid mail-back disposal envelopes with all opioid prescriptions. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet